As buyers confront another uncertain year for public equities, huge-cap health care stocks remain an beautiful defensive perform. They give a shot at insulating funds from the downturn lots of still be expecting to come.
That imagining buoyed the inventory price ranges of big healthcare providers in 2022. The
Health Treatment Choose Sector SDPR fund
(ticker: XLV), which tracks the healthcare sector, was down 4.6% in 2022 by way of Tuesday’s close, beating the broader
S&P 500
down about 20%.
As buyers confront another uncertain year for public equities, huge-cap health care stocks remain an beautiful defensive perform. They give a shot at insulating funds from the downturn lots of still be expecting to come.
That imagining buoyed the inventory price ranges of big healthcare providers in 2022. The
Health Treatment Choose Sector SDPR fund
(ticker: XLV), which tracks the healthcare sector, was down 4.6% in 2022 by way of Tuesday’s close, beating the broader
S&P 500
down about 20%.
